0 Comments
0 Shares
501 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Imfinzi 500mg Injection - a targeted immunotherapy for advanced cancer treatmentIt is an immunotherapy medication used to treat certain cancer types like non-small cell lung cancer, liver and biliary tract cancer. Imfinzi 500mg Injection contain an active ingredient called durvalumab that works to block PD-L1 protein so that immune system gets activated to kill cancer cells. Uses It can treat- Lung cancer(non small cell lung cancer/small cell lung cancer)...0 Comments 0 Shares 738 Views 0 Reviews
-
Lenvatinib Mesylate Capsules Market – Targeted Kinase Inhibition Expanding Cancer Treatment OptionsMarket Overview The Lenvatinib Mesylate capsules market is expanding as this multi-targeted kinase inhibitor gains broader use in treating thyroid, liver, kidney, and endometrial cancers. By blocking multiple growth signaling pathways, Lenvatinib helps slow tumor progression in patients with advanced or treatment-resistant malignancies. Rising cancer incidence, expanding regulatory approvals,...0 Comments 0 Shares 475 Views 0 Reviews
-
Liquid Biopsy Market Role in Personalized and Targeted Cancer Treatment 2031The Liquid Biopsy Market is gaining importance in treatment monitoring. Repeated blood-based testing can potentially provide information about changes in tumor biology without requiring repeated invasive tissue procedures. The Liquid Biopsy Market was estimated at US$ 4.57 billion in 2021 and is expected to reach US$ 12.69 million by 2031, registering an estimated CAGR of 11.2% through 2031....0 Comments 0 Shares 450 Views 0 Reviews
-
Neoantigen Targeted Therapy: The Personalized Cancer Treatment RevolutionCancer immunotherapy has transformed oncology, but one of its most promising frontiers is still emerging: neoantigen targeted therapy. Neoantigens are mutated proteins that arise in cancer cells and are recognized by the immune system as foreign. By targeting these cancer-specific markers, therapies can potentially attack tumors with precision while sparing healthy tissue. This approach is...0 Comments 0 Shares 240 Views 0 Reviews
-
Solid Tumors Market: Advancements in Cancer Treatment, Targeted Therapies, and Research DevelopmentsAccording to the latest report published by Data Bridge Market Research, the Solid Tumors Market Global solid tumors market size was valued at USD 362.21 billion in 2024 and is projected to reach USD 1557.42 billion by 2032, with a CAGR of 20.00% during the forecast period of 2025 to 2032. A large scale Solid Tumors Market research reports help business or organization in every sphere...0 Comments 0 Shares 719 Views 0 Reviews
-
US Metastatic Cancer Treatment Market Trends 2034: Advances in Targeted Therapies and ImmunotherapyUS Metastatic Cancer Treatment Market expansion is driven by the growing use of immunotherapy and targeted medicines. Treatment options are increasingly selected according to cancer type, molecular biomarkers, previous therapies, and individual patient characteristics. The Metastatic Cancer Treatment Market was valued at US$ 66.15 billion in 2025 and is projected to reach US$ 158.86 billion by...0 Comments 0 Shares 311 Views 0 Reviews
-
Injectable Targeted Therapy Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Injectable Targeted Therapy Market CAGR Value Injectable Targeted Therapy Market survey report is intended to help the readers develop a practical and intelligent approach to market dynamics and exploit opportunities, therefore. The market report also contains the drivers and restraints for the...0 Comments 0 Shares 2K Views 0 Reviews
-
Bevacizumab Market Outlook: Key Trends & Future GrowthAccording to the latest report published by Data Bridge Market Research, the Coal Tar Market CAGR ValueThe coal tar market size was valued at USD 16.54 billion in 2024 and is expected to reach USD 20.47 billion by 2032, at a CAGR of 2.70% during the forecast period. The large scale Coal Tar Market report evaluates CAGR value fluctuation during the forecast period for the market. All the...0 Comments 0 Shares 11 Views 0 Reviews
-
Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment OpportunitiesThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Comments 0 Shares 2K Views 0 Reviews
-
HDAC Inhibitor Market Segmentation Analysis by Indication and End UserThe global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...0 Comments 0 Shares 2K Views 0 Reviews
-
Pertuzumab Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Pertuzumab Market CAGR Value This Pertuzumab Marketdocument provides with CAGR value fluctuation during the forecast period for the market. The report provides wide-ranging statistical analysis of the market’s continuous positive developments, capacity, production, production value, cost/profit,...0 Comments 0 Shares 1K Views 0 Reviews
-
Regional Growth Prospects for the Ovarian Cancer Drugs MarketThe Ovarian Cancer Drugs Market is evolving as the need for effective cancer treatments increases worldwide. Valued at USD 3.4 billion in 2022, the Ovarian Cancer Drugs Market is projected to reach USD 5.7 billion by 2030, expanding at a CAGR of 6.6% from 2023 to 2030. Growing ovarian cancer incidence, advances in targeted medicines, and the development of innovative therapies are supporting...0 Comments 0 Shares 2K Views 0 Reviews
-
Thymus (T)-Cell Therapy Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Thymus (T)-Cell Therapy Market CAGR ValueThe Thymus (T)-Cell Therapy Market was valued at USD 10.76 billion in 2025 and is projected to reach USD 41.97 billion by 2033, growing at a CAGR of 18.55% from 2026 to 2033. The market is witnessing strong growth driven by the rising global burden of cancer and...0 Comments 0 Shares 318 Views 0 Reviews
More Results